Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aline Lazzarotti

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapie|November 5, 2005
[Medication errors resulting from drug preparation and administration]Christine Le Grognec, Aline Lazzarotti, Durnet-Archeray Marie-Joseph, et al.
Therapie|March 25, 2017
[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate]Jennifer Howlett, Christelle Prudent, Emmanuel De Maistre, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2019
[Who is at risk for drug-drug interactions in type 2 diabetic patients?]Claire Laurent, Ludwig Serge Aho Glele, Aline Lazzarotti, et al.
Presse Medicale (Paris, France : 1983)|April 24, 2007
[Good clinical practices and inpatient antibiotics: optimization of fluoroquinolone switch therapy]Baptiste Rigaud, Charlotte Malbranche, Virginie Pioud, et al.
Therapie|June 19, 2013
[Eculizumab: effectiveness of a shortened dosing schedule in the treatment of atypical haemolytic uremic syndrome of unknown origin]Florence Beye, Charlotte Malbranche, Delphine Tramecon, et al.
JAMA Ophthalmology|January 17, 2025
Temperature Excursion of Intravitreal Anti-VEGF Agents During Home StorageInès Ben Ghezala, Laure-Anne Steinberg, Maxime Sibert, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapie|November 5, 2005
[Medication errors resulting from drug preparation and administration]Christine Le Grognec, Aline Lazzarotti, Durnet-Archeray Marie-Joseph, et al.
Therapie|March 25, 2017
[Hemorrhage treatment: Evaluation of the proper use of fibrinogen concentrate]Jennifer Howlett, Christelle Prudent, Emmanuel De Maistre, et al.
Presse Medicale (Paris, France : 1983)|November 26, 2019
[Who is at risk for drug-drug interactions in type 2 diabetic patients?]Claire Laurent, Ludwig Serge Aho Glele, Aline Lazzarotti, et al.
Presse Medicale (Paris, France : 1983)|April 24, 2007
[Good clinical practices and inpatient antibiotics: optimization of fluoroquinolone switch therapy]Baptiste Rigaud, Charlotte Malbranche, Virginie Pioud, et al.
Therapie|June 19, 2013
[Eculizumab: effectiveness of a shortened dosing schedule in the treatment of atypical haemolytic uremic syndrome of unknown origin]Florence Beye, Charlotte Malbranche, Delphine Tramecon, et al.
JAMA Ophthalmology|January 17, 2025
Temperature Excursion of Intravitreal Anti-VEGF Agents During Home StorageInès Ben Ghezala, Laure-Anne Steinberg, Maxime Sibert, et al.
Pageof 1